The present invention relates, in general, to a cancer-related protein and to
a nucleic acid sequence encoding same. In particular, the invention relates to
a protein over expressed in certain neoplastic cells, including breast and ovarian
cancer cells, to its encoding sequence, and to diagnostic and treatment methodologies
based on same.